Get the Stockscreener App
34.45
1.53%
0.52
After Hours:
34.45
Phibro Animal Health Corp stock is traded at $34.45, with a volume of 206.58K.
It is up +1.53% in the last 24 hours and down -4.12% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$33.93
Open:
$33.93
24h Volume:
206.58K
Relative Volume:
0.85
Market Cap:
$1.40B
Revenue:
$1.50B
Net Income/Loss:
$95.23M
P/E Ratio:
14.80
EPS:
2.328
Net Cash Flow:
$12.77M
1W Performance:
-0.32%
1M Performance:
-4.12%
6M Performance:
-39.57%
1Y Performance:
-9.44%
1-Day Range:
$33.52
$34.66
1-Week Range:
$33.05
$36.04
52-Week Range:
$28.25
$60.08
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, TEVA, HLN, ZTS, VTRS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
34.45 | 1.40B | 1.50B | 95.23M | 12.77M | 2.328 |
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Neutral |
| Jul-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-16-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
Phibro Animal Health Corporation (PAHC) stock price, news, quote and history - Yahoo Finance Singapore
Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report? - Yahoo Finance
Phibro Animal Health Corporation (PAHC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Phibro Animal Health Corporatio (PAHC) Stock Forecasts - Yahoo Finance
Branded Pharmaceuticals Stocks Q2 In Review: Phibro Animal Health (NASDAQ:PAHC) Vs Peers - Yahoo Finance
Phibro Animal Health CFO David Glenn Granted 3,482 Shares, Increasing Holdings to 54,959 - Kalkine Media
Phibro Animal Health Corp Grants COO Miller Larry Lee 3,726 Shares, Increasing His Stake to 38,275 - Kalkine Media
Phibro Animal Health (PAHC) updates CFO’s 3,482-unit stock grant - Stock Titan
COO stock award takes Phibro Animal Health (PAHC) stake to 38,275 units - Stock Titan
Zacks.com featured highlights DiamondRock, Vertiv, Mueller Water Products and Phibro - Yahoo Finance
Big Phibro Animal Health (PAHC) investor lines up stock sale plan - Stock Titan
Does Phibro (PAHC) Have the Potential to Rally 25.77% as Wall Street Analysts Expect? - finance.yahoo.com
Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference - Yahoo Finance
Phibro Animal Health (PAHC) Sets 2027 Guidance, Is The Stock Still A Bargain? - Yahoo Finance
Phibro Animal Health Corp (PAHC) Shares Surge 3.9% -- What GF Sc - GuruFocus
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Understanding Phibro (PAHC) Reliance on International Revenue - Yahoo Finance
Phibro Animal Health Corporation Class A (PAHC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Teleconferência de Resultados do 4º Trimestre Fiscal e do Ano Fiscal de 2026 da PAHC: Crescimento das Vendas, Guidance para 2027 e Risco Brasil - TradingKey
PAHC Q2 Deep Dive: Diverse Portfolio Offsets Regulatory and Margin Headwinds - Yahoo Finance
Phibro Animal Health declares $0.12 quarterly dividend - scanx.trade
Earnings call transcript: Phibro Animal Health tops Q4 2026 estimates - Investing.com
Earnings call transcript: Phibro Animal Health tops Q4 2026 estimates By Investing.com - Investing.com India
PAHC SWOT Analysis: Strong Growth Potential Amidst Valuation Con - GuruFocus
Is Phibro Animal Health Corp (PAHC) Overvalued After Q4 Earnings - GuruFocus
Phibro Animal Health Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Phibro Animal Health Submits Annual 10-K Report for Fiscal Year Ending June 30, 2026 - Kalkine Media
(PAHC) Phibro Animal Health Expects Fiscal 2027 Revenue Range $1.55B$1.60B, vs. FactSet Est of $1.55B - marketscreener.com
Earnings Flash (PAHC) Phibro Animal Health Posts Fiscal Q4 Revenue $396.7M, vs. FactSet Est of $381.2M - marketscreener.com
Phibro Animal Health Corporation (PAHC) Stock Rises on Q4 2026 Earnings - Quiver Quantitative
Phibro Animal Health jumps 5% on strong Q4 earnings and guidance beat - Investing.com
PHIBRO ANIMAL HEALTH CORP FY 2026: Revenue $1.52B, EPS $2.43— 10-K Summary - TradingView
Phibro: Fiscal Q4 Earnings Snapshot - KVUE
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance - Yahoo Finance
Phibro Animal Health sets FY27 adj EPS $3.41-$3.59, beats est - scanx.trade
JPMorgan reiterates Phibro Animal Health stock rating on solid outlook By Investing.com - Investing.com Nigeria
Earnings To Watch: Phibro Animal Health (PAHC) Reports Q2 Results Tomorrow - Yahoo Finance
Phibro Animal Health Corp (PAHC) Shares Surge 3.2% -- What GF Sc - GuruFocus
Phibro (PAHC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
Is Phibro Animal Health (PAHC) Still Reasonable After A 149% Run? - Yahoo Finance
Phibro Animal Health (PAHC) Could Be 22% Undervalued On Upcoming Earnings - Yahoo Finance
Phibro Animal Health to report Q4 FY26 results on August 26 - scanx.trade
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results - Yahoo Finance Singapore
Phibro Animal Health Corporation (NASDAQ:PAHC) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Shares Cross Below 200 Day Moving AverageHere's What Happened - marketbeat.com
Phibro Animal Health (PAHC) Stock Looks Undervalued On Earnings Yet Mixed Elsewhere - simplywall.st
All News for PAHC : Phibro Animal Health - Zacks Investment Research
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):